中文名 | N-[(3S,5S)-5-甲基-3-哌啶基]-胺基甲酸乙酯-1,1-二甲基乙酯 |
---|---|
英文名 | tert-butyl N-[(3S,5S)-5-methylpiperidin-3-yl]carbamate |
中文别名 | N-[(3S,5S)-5-甲基-3-哌啶基]氨基甲酸叔丁酯 |
英文别名 |
I12-0525
(3S,5S)-3-(tert-butoxycarbonylamino)-5-methylpiperidine (5(S)-methylpiperidin-3(S)-yl)-carbamic acid tert-butyl ester PS-J-131 2-Methyl-2-propanyl [(3S,5S)-5-methyl-3-piperidinyl]carbamate (3S,5S)-(5-methyl-piperidin-3-yl)-carbamic acid tert-butyl ester Carbamic acid, N-[(3S,5S)-5-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester tert-butyl ((3S,5S)-5-methylpiperidin-3-yl)carbamate Carbamic acid,N-[(3S,5S)-5-methyl-3-piperidinyl]-,1,1-dimethylethyl ester |
密度 | 1.0±0.1 g/cm3 |
---|---|
沸点 | 313.4±31.0 °C at 760 mmHg |
分子式 | C11H22N2O2 |
分子量 | 214.305 |
闪点 | 143.4±24.8 °C |
精确质量 | 214.168121 |
PSA | 50.36000 |
LogP | 1.86 |
蒸汽压 | 0.0±0.7 mmHg at 25°C |
折射率 | 1.478 |
海关编码 | 2933399090 |
---|
~% 951163-61-4 |
文献:The Procter and Gamble Company Patent: US2007/232650 A1, 2007 ; Location in patent: Page/Page column 6 ; |
~% 951163-61-4 |
文献:TaiGen Biotechnology Co., Ltd. Patent: US2010/152452 A1, 2010 ; Location in patent: Page/Page column 10 ; |
~% 951163-61-4 |
文献:TaiGen Biotechnology Co., Ltd. Patent: US2010/152452 A1, 2010 ; Location in patent: Page/Page column 10-11 ; |
~% 951163-61-4 |
文献:TaiGen Biotechnology Co., Ltd. Patent: US2010/152452 A1, 2010 ; Location in patent: Page/Page column 13 ; |
~% 951163-61-4 |
文献:AMGEN INC.; D'AMICO, Derin C.; HERBERICH, Bradley J.; JACKSON, Claire L.M.; PETTUS, Liping H.; TASKER, Andrew; WANG, Hui-Ling; WU, Bin; WURZ, Ryan Patent: WO2012/148775 A1, 2012 ; WO 2012/148775 A1 |
~% 951163-61-4 |
文献:AMGEN INC.; D'AMICO, Derin C.; HERBERICH, Bradley J.; JACKSON, Claire L.M.; PETTUS, Liping H.; TASKER, Andrew; WANG, Hui-Ling; WU, Bin; WURZ, Ryan Patent: WO2012/148775 A1, 2012 ; WO 2012/148775 A1 |
上游产品 5 | |
---|---|
下游产品 0 |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |